Contributing to international exchange and innovation, the International Pharmaceutical Science Exchange Conference hosted by Haisco is held in Shanghai.

On April 20th, a cutting-edge pharmaceutical exchange conference between Chinese and foreign experts was held in Shanghai, organized by Haisco Medicine Group. Pharmaceutical experts from the International Pharmaceutical Federation (FIP) and several top domestic medical institutions gathered together to discuss key topics such as the application of artificial intelligence in hospital pharmacy, trends in global pharmaceutical and制药 science development, and the role of pharmacists in the healthcare system. This event aimed to create a efficient platform for exchanges and cooperation in the pharmaceutical field both domestically and internationally. Qiu Youping, Executive General Manager of Marketing at Haisco Medicine Group, and Zhang Ruijue, General Manager of the Large Client Department at Haisco Group's Marketing Center, attended the conference.

Compared to the international level, explore the integration of AI technology and pharmacy

The meeting focused on pharmaceutical technology innovation from a global perspective. PAUL Sinclair, President of the International Pharmaceutical Federation (FIP), and Lu Qianzhou, Supervisor of the Shanghai Pharmaceutical Society, pointed out in their opening speeches that in response to changes in the global healthcare system, deepening pharmaceutical cooperation between China and abroad, and promoting the intelligent upgrade of pharmaceutical services have become industry consensus.

During the theme sharing session,FIP experts shared in-depth insights on the application of cutting-edge technologies and global pharmaceutical development trends:

• AI empowering hospital pharmacy: Robert Moss, a member of the FIP technical advisory group, provided a detailed explanation on “the application of artificial intelligence in hospital pharmacy” and the implementation practices of the FIP framework, offering a practical reference model for the intelligent transformation of pharmacy in domestic medical institutions.

• Global Industry Outlook: Carola van der Hoeff, Chief Operating Officer and Conference Director of FIP, in conjunction with the upcoming 84th FIP World Conference on Pharmacy and Pharmaceutical Science, systematically outlined the latest developments and future directions in global pharmacy and pharmaceutical science.

Based on clinical practice, enhance the core value of pharmacists

With the change in healthcare models, the multi-dimensional expansion of the role of pharmacists has become a focus of the industry. During a special discussion on "how to enhance the role of pharmacists in healthcare," more than ten pharmaceutical experts from top tertiary hospitals in Shanghai engaged in in-depth closed-door exchanges.Experts attending the meeting reached an important consensus by combining real clinical and research data: the focus of pharmaceutical care is shifting from traditional drug provision to patient services.

Experts focused on discussing the key role and value enhancement pathways of pharmacists in promoting rational drug use, optimizing chronic disease management, and improving healthcare quality throughout the entire lifecycle, under the support of AI-driven information technology.

With platform support, Haisco provides continuous industrial collaboration.

During the meeting summary phase, Chen Zhenyu, the General Representative of FIP China, and Lu Qianzhou, the Supervisor President of the Shanghai Pharmaceutical Society, affirmed the forward-looking consensus reached during the meeting. They expressed gratitude to Haisco for providing a platform for this exchange, and outlined the direction for further deepening academic exchanges in pharmaceutical science between China and foreign countries.

The successful holding of this advanced academic conference on Chinese and foreign pharmacy research is an important practice for Haisco Medicine to support industry exchanges and promote innovative development in pharmacy. In the future, Haisco Pharmaceutical Group will continue to play a bridging role, establish more high-level industry exchange platforms, facilitate the integration of advanced pharmacy concepts and technologies at home and abroad, and contribute to the high-quality development of Chinese pharmacy through Haisco's efforts.

【Introduction to FIP Attendees】

• Paul Sinclair, President of the International Pharmaceutical Federation (FIP) and recipient of the Australian Order of Service. Mr. Sinclair has over 30 years of experience in community pharmacy operations. He has held various professional leadership positions in Australia, actively advocating for the expansion of pharmacists' practice scope, and providing professional services through community pharmacy. In 2019, he was awarded the Australian Order of Service and listed on the Australia Day Honours.

• Robert Moss, Vice President of FIP and member of FIP Technical Advisory Group. With a strong background in hospital pharmacy management, he is currently the Head of Critical Event Preparation and Shortage Response at the Dutch National Drug Coordination Center, as well as a professional nursing expert. He has served as a board member of the European Association of Hospital Pharmacists (EAHP), possessing extensive international experience in drug shortage response and pharmaceutical technology applications.

• Carola van der Hoeff is the Chief Operations Officer and Event Director of FIP. She has been with FIP since 2011 and possesses extensive experience in organizing large international academic conferences. She is responsible for managing the financial and physical resources of FIP, and works to achieve FIP’s global mission and enhance its international influence by optimizing operational strategies and expanding its global event portfolio.